Annual Total Long Term Liabilities
$74.73 M
-$287.06 M-79.34%
December 31, 2024
Summary
- As of March 12, 2025, LAB annual total long term liabilities is $74.73 million, with the most recent change of -$287.06 million (-79.34%) on December 31, 2024.
- During the last 3 years, LAB annual total long term liabilities has fallen by -$56.32 million (-42.98%).
- LAB annual total long term liabilities is now -82.55% below its all-time high of $428.33 million, reached on December 31, 2022.
Performance
LAB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$74.73 M
+$3.14 M+4.38%
December 31, 2024
Summary
- As of March 12, 2025, LAB quarterly total long term liabilities is $74.73 million, with the most recent change of +$3.14 million (+4.38%) on December 31, 2024.
- Over the past year, LAB quarterly long term liabilities has stayed the same.
- LAB quarterly long term liabilities is now -82.85% below its all-time high of $435.81 million, reached on June 30, 2022.
Performance
LAB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LAB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.3% | 0.0% |
| 3 y3 years | -43.0% | -82.3% |
| 5 y5 years | -4.7% | -82.3% |
LAB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | at low | -82.8% | +4.4% |
| 5 y | 5-year | -82.5% | at low | -82.8% | +4.4% |
| alltime | all time | -82.5% | +4956.0% | -82.8% | +7190.5% |
Standard BioTools Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $74.73 M(-79.3%) | $74.73 M(+4.4%) |
| Sep 2024 | - | $71.59 M(-4.1%) |
| Jun 2024 | - | $74.66 M(-5.2%) |
| Mar 2024 | - | $78.80 M(-78.2%) |
| Dec 2023 | $361.79 M(-15.5%) | $361.79 M(-13.7%) |
| Sep 2023 | - | $419.20 M(-0.8%) |
| Jun 2023 | - | $422.37 M(-0.6%) |
| Mar 2023 | - | $425.02 M(-0.8%) |
| Dec 2022 | $428.33 M(+226.8%) | $428.33 M(-0.7%) |
| Sep 2022 | - | $431.49 M(-1.0%) |
| Jun 2022 | - | $435.81 M(+115.1%) |
| Mar 2022 | - | $202.65 M(+54.6%) |
| Dec 2021 | $131.05 M(-0.3%) | $131.05 M(-3.3%) |
| Sep 2021 | - | $135.56 M(+6.7%) |
| Jun 2021 | - | $127.02 M(-1.3%) |
| Mar 2021 | - | $128.73 M(-2.1%) |
| Dec 2020 | $131.46 M(+67.7%) | - |
| Dec 2020 | - | $131.46 M(+2.5%) |
| Sep 2020 | - | $128.21 M(+15.2%) |
| Jun 2020 | - | $111.28 M(-1.8%) |
| Mar 2020 | - | $113.36 M(+44.6%) |
| Dec 2019 | $78.38 M(-59.6%) | - |
| Dec 2019 | - | $78.38 M(+6.7%) |
| Sep 2019 | - | $73.42 M(-0.6%) |
| Jun 2019 | - | $73.83 M(-1.6%) |
| Mar 2019 | - | $75.02 M(-61.3%) |
| Dec 2018 | $193.95 M(-13.0%) | $193.95 M(+1.5%) |
| Sep 2018 | - | $191.01 M(+1.8%) |
| Jun 2018 | - | $187.62 M(+0.1%) |
| Mar 2018 | - | $187.42 M(-15.9%) |
| Dec 2017 | $222.94 M | $222.94 M(+0.9%) |
| Sep 2017 | - | $221.04 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $220.45 M(-1.0%) |
| Mar 2017 | - | $222.68 M(-0.4%) |
| Dec 2016 | $223.66 M(-0.6%) | $223.66 M(-0.4%) |
| Sep 2016 | - | $224.53 M(-0.4%) |
| Jun 2016 | - | $225.46 M(+0.2%) |
| Mar 2016 | - | $224.94 M(-0.1%) |
| Dec 2015 | $225.07 M(-1.2%) | $225.07 M(-0.8%) |
| Sep 2015 | - | $226.88 M(-0.0%) |
| Jun 2015 | - | $226.98 M(-0.3%) |
| Mar 2015 | - | $227.67 M(-0.0%) |
| Dec 2014 | $227.75 M(+8831.6%) | $227.75 M(-0.3%) |
| Sep 2014 | - | $228.53 M(-0.0%) |
| Jun 2014 | - | $228.61 M(-1.3%) |
| Mar 2014 | - | $231.56 M(+8980.6%) |
| Dec 2013 | $2.55 M(+72.5%) | $2.55 M(+16.7%) |
| Sep 2013 | - | $2.19 M(+11.9%) |
| Jun 2013 | - | $1.95 M(+24.0%) |
| Mar 2013 | - | $1.58 M(+6.6%) |
| Dec 2012 | $1.48 M(-34.5%) | $1.48 M(+12.7%) |
| Sep 2012 | - | $1.31 M(+5.2%) |
| Jun 2012 | - | $1.25 M(+21.6%) |
| Mar 2012 | - | $1.02 M(-54.6%) |
| Dec 2011 | $2.26 M(-98.8%) | $2.26 M(-40.4%) |
| Sep 2011 | - | $3.79 M(-32.2%) |
| Jun 2011 | - | $5.59 M(-24.5%) |
| Mar 2011 | - | $7.41 M(-96.2%) |
| Dec 2010 | $195.46 M(-1.6%) | $195.46 M(+1515.9%) |
| Sep 2010 | - | $12.10 M(-93.9%) |
| Dec 2009 | $198.64 M(+9.0%) | $198.64 M(+9.0%) |
| Dec 2008 | $182.17 M(+5.0%) | $182.17 M(+1.9%) |
| Jun 2008 | - | $178.84 M(+3.1%) |
| Dec 2007 | $173.53 M(+28.1%) | $173.53 M |
| Dec 2006 | $135.51 M | - |
FAQ
- What is Standard BioTools annual total long term liabilities?
- What is the all time high annual total long term liabilities for Standard BioTools?
- What is Standard BioTools annual total long term liabilities year-on-year change?
- What is Standard BioTools quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Standard BioTools?
- What is Standard BioTools quarterly long term liabilities year-on-year change?
What is Standard BioTools annual total long term liabilities?
The current annual total long term liabilities of LAB is $74.73 M
What is the all time high annual total long term liabilities for Standard BioTools?
Standard BioTools all-time high annual total long term liabilities is $428.33 M
What is Standard BioTools annual total long term liabilities year-on-year change?
Over the past year, LAB annual total long term liabilities has changed by -$287.06 M (-79.34%)
What is Standard BioTools quarterly total long term liabilities?
The current quarterly long term liabilities of LAB is $74.73 M
What is the all time high quarterly long term liabilities for Standard BioTools?
Standard BioTools all-time high quarterly total long term liabilities is $435.81 M
What is Standard BioTools quarterly long term liabilities year-on-year change?
Over the past year, LAB quarterly total long term liabilities has changed by $0.00 (0.00%)